Iron-Reduced Graphene Oxide Core-Shell Micromotors Designed for Magnetic Guidance and Photothermal Therapy under Second Near-Infrared Light.

cancer core–shell micromotors magnetic guidance photothermal effect photothermal therapy reduced graphene oxide

Journal

Pharmaceutics
ISSN: 1999-4923
Titre abrégé: Pharmaceutics
Pays: Switzerland
ID NLM: 101534003

Informations de publication

Date de publication:
25 Jun 2024
Historique:
received: 14 05 2024
revised: 17 06 2024
accepted: 20 06 2024
medline: 27 7 2024
pubmed: 27 7 2024
entrez: 27 7 2024
Statut: epublish

Résumé

Core-shell micro/nanomotors have garnered significant interest in biomedicine owing to their versatile task-performing capabilities. However, their effectiveness for photothermal therapy (PTT) still faces challenges because of their poor tumor accumulation, lower light-to-heat conversion, and due to the limited penetration of near-infrared (NIR) light. In this study, we present a novel core-shell micromotor that combines magnetic and photothermal properties. It is synthesized via the template-assisted electrodeposition of iron (Fe) and reduced graphene oxide (rGO) on a microtubular pore-shaped membrane. The resulting Fe-rGO micromotor consists of a core of oval-shaped zero-valent iron nanoparticles with large magnetization. At the same time, the outer layer has a uniform reduced graphene oxide (rGO) topography. Combined, these Fe-rGO core-shell micromotors respond to magnetic forces and near-infrared (NIR) light (1064 nm), achieving a remarkable photothermal conversion efficiency of 78% at a concentration of 434 µg mL

Identifiants

pubmed: 39065553
pii: pharmaceutics16070856
doi: 10.3390/pharmaceutics16070856
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Agencia Nacional de Investigación y Desarrollo
ID : 11200416
Organisme : Agencia Nacional de Investigación y Desarrollo
ID : FOVI220173

Déclaration de conflit d'intérêts

The authors declare no conflicts of interest.

Auteurs

Orlando Donoso-González (O)

Departamento Química Farmacológica y Toxicológica, Facultad de Ciencias Químicas y Farmacéuticas, Universidad de Chile, Sergio Livingstone #1007, Independencia, Santiago 8380492, Chile.
Advanced Center for Chronic Diseases (ACCDiS), Universidad de Chile, Sergio Livingstone #1007, Independencia, Santiago 8380492, Chile.

Ana L Riveros (AL)

Departamento Química Farmacológica y Toxicológica, Facultad de Ciencias Químicas y Farmacéuticas, Universidad de Chile, Sergio Livingstone #1007, Independencia, Santiago 8380492, Chile.
Advanced Center for Chronic Diseases (ACCDiS), Universidad de Chile, Sergio Livingstone #1007, Independencia, Santiago 8380492, Chile.

José F Marco (JF)

Instituto de Química Física Blas Cabrera, Consejo Superior de Investigaciones Científicas (CSIC), Serrano 119, 28006 Madrid, Spain.

Diego Venegas-Yazigi (D)

Departamento de Química de los Materiales, Facultad de Química y Biología, Universidad de Santiago de Chile, Libertador Bernardo O'Higgins #3363, Estación Central, Santiago 9170022, Chile.
Centro para el Desarrollo de La Nanociencia y la Nanotecnología (CEDENNA), Universidad de Santiago de Chile, Libertador Bernardo O'Higgins #3363, Estación Central, Santiago 9170022, Chile.

Verónica Paredes-García (V)

Centro para el Desarrollo de La Nanociencia y la Nanotecnología (CEDENNA), Universidad de Santiago de Chile, Libertador Bernardo O'Higgins #3363, Estación Central, Santiago 9170022, Chile.
Departamento de Ciencias Químicas, Facultad de Ciencias Exactas, Universidad Andrés Bello, República 275, Santiago, Santiago 8370146, Chile.

Camila F Olguín (CF)

Escuela de Medicina, Universidad de Talca, Talca 3460000, Chile.

Cristina Mayorga-Lobos (C)

Advanced Center for Chronic Diseases (ACCDiS), Universidad de Chile, Sergio Livingstone #1007, Independencia, Santiago 8380492, Chile.
Cellular Communication Laboratory, Center for Studies on Exercise, Metabolism and Cancer (CEMC), Institute of Biomedical Sciences (ICBM), Faculty of Medicine, University of Chile, Santiago 8380492, Chile.

Lorena Lobos-González (L)

Cellular Communication Laboratory, Center for Studies on Exercise, Metabolism and Cancer (CEMC), Institute of Biomedical Sciences (ICBM), Faculty of Medicine, University of Chile, Santiago 8380492, Chile.
Center for Regenerative Medicine, Institute for Sciences and Innovation in Medicine, Facultad de Medicina, Clínica Alemana Universidad del Desarrollo, Santiago 7610658, Chile.

Felipe Franco-Campos (F)

Research Group in Alternative Methods for Determining Toxics Effects and Risk Assessment of Contaminants and Mixtures (RiskTox), Laboratory of Food Chemistry and Toxicology, Faculty of Pharmacy, University of Valencia, 46100 Valencia, Spain.

Joseph Wang (J)

Department of Nanoengineering, University of California San Diego, La Jolla, CA 92093, USA.

Marcelo J Kogan (MJ)

Departamento Química Farmacológica y Toxicológica, Facultad de Ciencias Químicas y Farmacéuticas, Universidad de Chile, Sergio Livingstone #1007, Independencia, Santiago 8380492, Chile.
Advanced Center for Chronic Diseases (ACCDiS), Universidad de Chile, Sergio Livingstone #1007, Independencia, Santiago 8380492, Chile.

Soledad Bollo (S)

Departamento Química Farmacológica y Toxicológica, Facultad de Ciencias Químicas y Farmacéuticas, Universidad de Chile, Sergio Livingstone #1007, Independencia, Santiago 8380492, Chile.
Advanced Center for Chronic Diseases (ACCDiS), Universidad de Chile, Sergio Livingstone #1007, Independencia, Santiago 8380492, Chile.
Centro de Investigación de Procesos Redox, CIPRex, Facultad de Ciencias Químicas y Farmacéuticas, Universidad de Chile, Sergio Livingstone #1007, Independencia, Santiago 8380492, Chile.

Claudia Yañez (C)

Centro de Investigación de Procesos Redox, CIPRex, Facultad de Ciencias Químicas y Farmacéuticas, Universidad de Chile, Sergio Livingstone #1007, Independencia, Santiago 8380492, Chile.
Departamento de Química Orgánica y Fisicoquímica, Facultad de Ciencias Químicas y Farmacéuticas, Universidad de Chile, Sergio Livingstone #1007, Independencia, Santiago 8380492, Chile.

Daniela F Báez (DF)

Advanced Center for Chronic Diseases (ACCDiS), Universidad de Chile, Sergio Livingstone #1007, Independencia, Santiago 8380492, Chile.
Escuela de Medicina, Universidad de Talca, Talca 3460000, Chile.

Classifications MeSH